4.7 Article

Coagulopathy in Critically Ill Patients Part 2-Soluble Clotting Factors and Hemostatic Testing

Journal

CHEST
Volume 137, Issue 1, Pages 185-194

Publisher

ELSEVIER
DOI: 10.1378/chest.08-2535

Keywords

-

Funding

  1. Novo-Nordisc and Eli Lilly
  2. Sanofi-Aventis

Ask authors/readers for more resources

This manuscript provides an overview of how to interpret in vitro clotting studies and how to select studies to evaluate patients with bleeding disorders in the ICU. It provides a practical approach to understanding the complex subject of clotting factor abnormalities, including the most common problems of preanalytical error and anticoagulation therapy. Limitations and pitfalls of diagnostic testing are highlighted. CHEST 2010; 137(1):185-194

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available